Atrás
Rango del Día
$3.43
$3.58
Rango de 52 Semanas
$1.11
$6.94
Volumen
2,181,379
Promedio 50D / 200D
$3.86
/
$3.93
Cierre Anterior
$3.59
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3.2 | 0.3 |
| P/B | 5.3 | 2.9 |
| ROE % | -146.8 | 3.7 |
| Net Margin % | -4342.4 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 1.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$17.25
+390.1%
Low: $12.00
High: $23.00
EPS Futuro
-$0.91
Ingresos Est.
22 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$0.78
-$2.06 – -$0.07
|
60 M | 6 |
| FY2029 |
-$0.88
-$2.33 – -$0.08
|
19 M | 6 |
| FY2028 |
-$0.79
-$1.10 – -$0.59
|
48 M | 8 |
Puntos Clave
Negative free cash flow of -167.10M
PEG of 0.14 suggests growth is underpriced
Capital intensive — 97.82% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)55.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-146.81%
ROIC-65.85%
Net Margin-4342.44%
Op. Margin-4498.06%
Seguridad
Debt / Equity
0.96
Current Ratio4.84
Interest Coverage0.00
Valoración
P/E Ratio
-3.16
P/B Ratio5.26
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 55.28% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.63M | Net Income (TTM) | -201.14M |
| ROE | -146.81% | ROA | -58.69% |
| Gross Margin | -58.05% | Operating Margin | -4498.06% |
| Net Margin | -4342.44% | Free Cash Flow (TTM) | -167.10M |
| ROIC | -65.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.96 | Current Ratio | 4.84 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.16 | P/B Ratio | 5.26 |
| P/S Ratio | 137.21 | PEG Ratio | 0.14 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 635.54M | Enterprise Value | 688.94M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.63M | 2.98M | 0.0 | 0.0 | 0.0 |
| Net Income | -201.14M | -195.88M | -198.13M | -121.82M | -165.37M |
| EPS (Diluted) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 |
| Gross Profit | -2.69M | 2.98M | 0.0 | 0.0 | 0.0 |
| Operating Income | -208.35M | -202.47M | -204.79M | -116.54M | -84.47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 342.73M | 297.51M | 193.85M | 360.31M | 301.86M |
| Total Liabilities | 221.87M | 144.36M | 60.78M | 44.04M | 62.30M |
| Shareholders' Equity | 120.87M | 153.15M | 133.07M | 316.27M | 239.56M |
| Total Debt | 116.43M | 40.79M | 13.63M | 28.75M | 10.41M |
| Cash & Equivalents | 63.03M | 182.48M | 41.57M | 187.62M | 185.42M |
| Current Assets | 181.29M | 211.89M | 142.98M | 296.62M | 270.58M |
| Current Liabilities | 37.45M | 37.96M | 56.42M | 26.71M | 57.98M |